Regenity is the trusted Contract Development and Manufacturing partner delivering the biomaterials, precision, and quality behind regenerative innovation.
Paramus, N.J., October 2025 — Regenity Biosciences, a global leader in regenerative biomaterials and contract development and manufacturing (CDM) partner for the medtech community, announced its participation in MEDICA 2025, the world’s largest exhibition for medical technology and healthcare advancement, taking place November 17–20 in Düsseldorf, Germany. Regenity will exhibit in Hall 10, Booth 10F57.
Each year, MEDICA attracts more than 5,000 exhibitors and 80,000 attendees from across the global healthcare and medical technology industry.¹ The event brings together product innovators, R&D specialists, and manufacturing partners—fostering ideas and collaboration that advance medicine worldwide.
At MEDICA 2025, Regenity will showcase how its global CDM business model supports the design, development, and scalability of regenerative and bioresorbable medical devices. With FDA-registered and ISO 13485-certified facilities in the United States and Europe, Regenity delivers end-to-end capabilities—from early-stage design and materials engineering to full-scale manufacturing production—helping partners advance regenerative technologies with precision and reliability.
Regenity applies its three core technology platforms—collagen, synthetic polymers, and bioceramics—to engineer regenerative solutions that restore and reinforce the body’s natural healing processes. By leveraging deep materials science expertise spanning nearly three decades, Regenity customizes these biomaterials for specific mechanical, biological, and resorption profiles across medical specialties. Collagen provides biologically active scaffolds that promote tissue regeneration, polymers deliver tunable strength and controlled resorption, and bioceramics contribute osteoconductive structure for bone integration. Together, these platforms enable Regenity to design and manufacture advanced implants for its medtech partners that make a material difference for more than 4 million patients around the world each year.
Stop by the Regenity Booth 10F57 for a hands-on demo to see, touch, and understand how Regenity’s collagen, polymer, and bioceramic platforms enable next-generation medical devices. To schedule a meeting in advance, email [email protected] or visit www.regenity.com for more information.
The Regenity team attending MEDICA 2025 includes:
- Sean Stevenson, Senior Director, Strategic Alliances
- Johan Van Havermaet, Senior Director, Business Development
- Stephen Noland, Portfolio Management Director
- Martin Tooren, Director, R&D
- Konstantin Denisov, R&D Technician
- Maarten Sleiderink, R&D Technician
¹ Source: MEDICA Trade Fair – Facts & Figures